Notice2024-28075
Meetings of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 29, 2024
Issuing agencies
Health and Human Services Department
Abstract
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that an in-person meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); the main focus of the meeting is to solicit feedback from invited presenters and members of the public on the 2025-2020 National Action Plan on Combating Antibiotic Resistant Bacteria. The meeting will be open to the public as well as streamed live on hhs.gov/live. A pre- registered public comment and innovation spotlight session will be held during the meeting. Pre-registration is required for members of the public who wish to present their comments or innovations live during the meeting.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 230 (Friday, November 29, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Pages 94748-94749]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-28075]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meetings of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that an in-person meeting is scheduled to be held for the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB);
the main focus of the meeting is to solicit feedback from invited
presenters and members of the public on the 2025-2020 National Action
Plan on Combating Antibiotic Resistant Bacteria. The meeting will be
open to the public as well as streamed live on <a href="http://hhs.gov/live">hhs.gov/live</a>. A pre-
registered public comment and innovation spotlight session will be held
during the meeting. Pre-registration is required for members of the
public who wish to present their comments or innovations live during
the meeting.
DATES: The meeting is scheduled to be held on January 28-29, 2025, from
9 a.m. to 5 p.m. ET (times are tentative and subject to change). The
confirmed times and agenda items for the meeting will be posted on the
website for the PACCARB at <a href="https://www.hhs.gov/paccarb">https://www.hhs.gov/paccarb</a> when this
information becomes available. Pre-registration for attending the
meeting is strongly suggested and should be completed no later than
January 24, 2025.
ADDRESSES: The meeting will be held in-person at The Ritz-Carlton,
Pentagon City, 1250 S. Hayes St., Arlington, VA 22202. The meeting will
also be live streamed and can be accessed through a live webcast on the
day of the meeting. Additional instructions regarding attending this
meeting virtually will be posted at least one week prior to the meeting
at: <a href="https://www.hhs.gov/paccarb">https://www.hhs.gov/paccarb</a>.
Individuals who wish to send in their written public comment should
submit it via email to <a href="/cdn-cgi/l/email-protection#7536342737351d1d065b121a03"><span class="__cf_email__" data-cfemail="3271736070725a5a411c555d44">[email protected]</span></a>. Registration information is
available on the website <a href="https://www.hhs.gov/paccarb">https://www.hhs.gov/paccarb</a> and must be
completed by January 24, 2025, to attend the January 28-29, 2025,
public meeting or by January 21, 2025, to provide public comment or
innovation spotlight at the meeting. Additional information about
registering for the meeting and providing public comment can be
obtained at <a href="https://www.hhs.gov/paccarb">https://www.hhs.gov/paccarb</a> on the Upcoming Meetings page.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: 202-746-1512; Email: <a href="/cdn-cgi/l/email-protection#6f2c2e3d2d2f07071c41080019"><span class="__cf_email__" data-cfemail="86c5c7d4c4c6eeeef5a8e1e9f0">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (PACCARB), established by
Executive Order 13676, is continued by section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are
governed by the provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C. app.), which sets forth
standards for the formation and use of Federal advisory committees.
The PACCARB shall advise and provide information and
recommendations to the Secretary of Health and Human Services
(Secretary) regarding programs and policies intended to reduce or
combat antibiotic-resistant bacteria that may present a public health
threat and improve capabilities to prevent, diagnose, mitigate, or
treat such resistance. The PACCARB shall function solely for advisory
purposes.
Such advice, information, and recommendations may be related to
improving: the effectiveness of antibiotics; research and advanced
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
[[Page 94749]]
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States
capabilities to combat antibiotic resistance.
The focus of the January 28-29, 2025, meeting is to provide input
and information to the Combating Antibiotic-Resistant Bacteria (CARB)
Federal Task Force as they develop the next five-year iteration of the
CARB National Action Plan 2025-2030. The meeting will focus on
innovative and emerging topics in antimicrobial resistance (AMR), as
well as insights from international CARB counterparts. The topics
presented at the public meeting include: an overview of other partner
country CARB National Action Plans; methods to measure global awareness
of AMR; the impact of AMR and food security; AMR as a national security
threat; a reflection on the United Nations General Assembly Political
Declaration by Federal agencies; the economics of AMR; innovations to
combat AMR; among other topics.
Members of the public are invited to provide comment, especially on
the 2025-2030 CARB National Action Plan, during an extended public
comment session, in-person during the meeting by pre-registering online
at <a href="https://www.hhs.gov/paccarb">https://www.hhs.gov/paccarb</a>; pre-registration is required for
participation in this session. Additionally, companies or organizations
working to combat antimicrobial resistance my share their innovation
during the January meeting by pre-registering to speak during the
meeting's Innovation Spotlight. Pre-registration online at <a href="https://www.hhs.gov/paccarb">https://www.hhs.gov/paccarb</a> is required for participation in this session, and
limited spots are available. The meeting agenda will be posted on the
PACCARB website at <a href="https://www.hhs.gov/paccarb">https://www.hhs.gov/paccarb</a> when it has been
finalized. All agenda items are tentative and subject to change.
Instructions regarding attending the meeting virtually will be posted
at least one week prior to the meeting at: <a href="https://www.hhs.gov/paccarb">https://www.hhs.gov/paccarb</a>.
For those unable to attend in person, but who wish to provide input
into the next iteration of the CARB National Action Plan 2025-2030, may
provide written public comments that can be emailed to <a href="/cdn-cgi/l/email-protection#7a393b28383a121209541d150c"><span class="__cf_email__" data-cfemail="bdfefceffffdd5d5ce93dad2cb">[email protected]</span></a> by
midnight January 21, 2025. All public comments received via email prior
to January 21, 2025, will be provided to the PACCARB and Interagency
CARB Task Force members.
Dated: November 18, 2024.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health.
[FR Doc. 2024-28075 Filed 11-27-24; 8:45 am]
BILLING CODE 4150-44-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 29, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.